Medovyne

Aciclovir, the active ingredient in Medovyne, is an antiviral presented as an intravenous solution for intravenous use. It treats herpes simplex virus infections, herpes zoster (shingles), and varicella (chickenpox) in patients requiring systemic therapy, including severe or disseminated cases where oral treatment is insufficient.

GNH USA supplies Medovyne as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, providing reliable sourcing and regulatory support for institutional buyers.

Aciclovir acts on herpesvirus infections and is used in systemic therapy for the following conditions:

Herpes simplex virus infections: reduces lesion duration and viral shedding in immunocompetent and immunocompromised patients. Herpes zoster (shingles): alleviates pain and accelerates lesion healing in acute infection. Varicella (chickenpox): limits disease severity and complications in severe or disseminated cases.

Adverse reactions may occur with intravenous aciclovir administration.

Common Side Effects: - Nausea or vomiting - Headache - Diarrhea - Injection site discomfort - Transient elevation of liver enzymes - Mild rash

Serious or Rare Side Effects: - Acute renal failure, especially in patients with pre‑existing kidney impairment - Severe hypersensitivity reactions, including anaphylaxis - Neurotoxicity presenting as confusion, seizures, or hallucinations

Use of Medovyne requires careful clinical assessment and monitoring.

Renal function: monitor renal function and adjust infusion rate in patients with impaired clearance. Hydration: ensure adequate hydration to reduce nephrotoxicity risk. Allergy: discontinue if hypersensitivity reactions occur. Pregnancy: use only if benefit outweighs risk; data limited. Concomitant nephrotoxic drugs: avoid or monitor closely. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Aciclovir may interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Probenecid: may increase aciclovir plasma levels, raising toxicity risk. - Cimetidine: can reduce renal clearance, leading to higher systemic exposure. - Nephrotoxic agents (e.g., aminoglycosides): combined use may amplify renal toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: may affect renal function, requiring renal monitoring. - Other antivirals (e.g., valacyclovir): additive antiviral effect, monitor for toxicity. - Loop diuretics: can exacerbate renal impairment when used together.